Figure 2. Swimmers plot of individual patient progression-free survival.

Bars with solid colors indicate prior maintenance therapy: green indicates prior bevacizumab (bev) therapy; red indicates prior poly(ADP-ribose) polymerase inhibitor (PARPi) therapy; purple indicates prior bev and PARPi therapy; and black indicates no prior therapy. Bars with hashed marks represent the number of prior lines of therapy. Arrows indicate that no disease progression was found at the time of analysis. Number on the x axis indicate months of progression-free survival.